- Conditions
- End Stage Renal Disease, End Stage Renal Disease on Dialysis, Dialysis Hypotension, Dialysis Induced Hypertension
- Interventions
- Intermittent Non-InvasiveBlood Pressure Monitor
- Device
- Lead sponsor
- The Rogosin Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated Jun 10, 2025 · Synced May 21, 2026, 11:51 PM EDT